Pioglitazone, a medication approved for treatment of type 2 diabetes, can help bypass genetic defects in chronic granulomatous disease to help white blood cells fight bacterial infections, according to researchers at National Jewish Health.
from The Medical News http://ift.tt/17l6MZE
from The Medical News http://ift.tt/17l6MZE
No comments:
Post a Comment